These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11113520)

  • 1. Increased DOI-induced head shakings in adult rats neonatally treated with MK-801.
    Kurumaji A; Aihara O; Yamada S; Toru M
    Brain Res Dev Brain Res; 2000 Nov; 124(1-2):125-7. PubMed ID: 11113520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MK-801-induced and scopolamine-induced hyperactivity in rats neonatally treated chronically with MK-801.
    Furuie H; Yamada K; Ichitani Y
    Behav Pharmacol; 2013 Dec; 24(8):678-83. PubMed ID: 24113081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate and long-term effects of neonatal MK-801 treatment on nonspatial learning.
    Griesbach GS; Amsel A
    Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11435-9. PubMed ID: 9736754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI).
    Li Q; Brownfield MS; Battaglia G; Cabrera TM; Levy AD; Rittenhouse PA; van de Kar LD
    J Pharmacol Exp Ther; 1993 Aug; 266(2):836-44. PubMed ID: 8394920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the repeated administration of the compound 3,4-methylenedioxymethamphetamine on the response of rats to the 5-HT2A,C receptor agonist (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
    Granoff MI; Ashby CR
    Neuropsychobiology; 1998; 37(1):36-40. PubMed ID: 9438270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of NMDA receptors in neonatal cocaine-induced neurotoxicity.
    Huber JD; Darling SF; Park KK; Soliman KF
    Pharmacol Biochem Behav; 2001; 69(3-4):451-9. PubMed ID: 11509204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
    Bell JA; Beglan CL
    Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of NMDA receptor subunit mRNA after MK-801 treatment in neonatal rats.
    Wilson MA; Kinsman SL; Johnston MV
    Brain Res Dev Brain Res; 1998 Aug; 109(2):211-20. PubMed ID: 9729392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-induced serotonin 2A receptor desensitization in the rat frontal cortex and hypothalamus.
    Damjanoska KJ; Heidenreich BA; Kindel GH; D'Souza DN; Zhang Y; Garcia F; Battaglia G; Wolf WA; Van de Kar LD; Muma NA
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1043-50. PubMed ID: 14976228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of 5-HT(2A) receptor mRNA levels and binding sites in rat frontal cortex by the agonist DOI and the antagonist mianserin.
    Anji A; Kumari M; Sullivan Hanley NR; Bryan GL; Hensler JG
    Neuropharmacology; 2000 Aug; 39(11):1996-2005. PubMed ID: 10963743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-monotonic dependency of PPI on temporal parameters: differential alteration by ketamine and MK-801 as opposed to apomorphine and DOI.
    Canal NM; Gourevitch R; Sandner G
    Psychopharmacology (Berl); 2001 Jul; 156(2-3):169-76. PubMed ID: 11549219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
    Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
    J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
    Johansson-Wallsten CE; Berg M; Meyerson BJ
    Eur J Pharmacol; 1993 Oct; 243(2):149-54. PubMed ID: 8276064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role of protein kinase C in regulation of 5-hydroxytryptamine 2A receptors in rat brain.
    Rahimian R; Hrdina PD
    Can J Physiol Pharmacol; 1995 Dec; 73(12):1686-91. PubMed ID: 8834481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action.
    López-Gil X; Artigas F; Adell A
    Int J Neuropsychopharmacol; 2009 May; 12(4):487-99. PubMed ID: 18752722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE; Johnson KB; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on plasma glucose and glucagon levels of rats.
    Sugimoto Y; Yamada J
    Biol Pharm Bull; 2000 Dec; 23(12):1521-3. PubMed ID: 11145190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
    Willins DL; Meltzer HY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):699-706. PubMed ID: 9262333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT 2A/2C receptors.
    Su YA; Si TM; Zhou DF; Guo CM; Wang XD; Yang Y; Shu L; Liang JH
    Eur J Pharmacol; 2007 Jun; 564(1-3):123-30. PubMed ID: 17395179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.